Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Phillips, Robert S ^a   Gibson, Faith ^b   Gopaul, Shireen ^c   Light, Kate ^a   Craig, Jean V ^d   Pizer, Barry ^e  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE; CANNABINOID;

CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHILDHOOD CANCER; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 70349108782     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007786     Document Type: Review

References (17)

1. Antonarakis ES, Evans JL, Heard GF, Noonan LM, Pizer BL, Hain RDW. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?. Pediatric Blood and Cancer 2004;43(6):651-658
2. Antonarakis ES, Hain RDW. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice. Archives of Disease in Childhood 2004;89(9):877-880
3. Corapcioglu F, Sarper N. A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer. Pediatric Hematology and Oncology 2005;22(2):103-114 (Pubitemid 40315509)
4. Cotanch P, Hockenberry M, Herman. Self-hypnosis as antiemetic therapy in children receiving chemotherapy. Oncology Nursing Forum 1985;12(4):41-46
5. Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an antiemetic in children. Paediatric Drugs 2001;3(6):441-479 (Pubitemid 32589000)
6. Dolgin MJ, Katz ER, McGinty K, Siegel SE. Anticipatory nausea and vomiting in pediatric cancer patients. Pediatrics 1985;75(3):547-552 (Pubitemid 15144673)
7. Dolgin MJ, Katz ER, Zeltzer LK, Landsverk J. Behavioral distress in pediatric patients with cancer receiving chemotherapy. Pediatrics 1989;84(1):103-110 (Pubitemid 19168046)
8. Foot AB, Hayes C. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Archives of Disease in Childhood 1994;71(5):475-480 (Pubitemid 24349864)
9. Hedstrom M, Haglund K, Skolin I, von Essen L. Distressing events for children and adolescents with cancer: Child, parent, and nurse perceptions. Journal of Pediatric Oncology Nursing 2003;20(3):120-132 (Pubitemid 38251128)
10. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org.
11. Holdsworth MT, Raisch DW, Frost J. Acute and delayed nausea and emesis control in pediatric oncology patients. Cancer 2006;106(4): 931-940 (Pubitemid 43238462)
12. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
13. Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. European Journal of Cancer Care 2007;16(5):402-412
14. Sandoval C, Corbi D, Strobino B, Fevzi Ozkaynak M, Tugal O, Jayabose S. Randomized double-blind comparison of single high-dose ondansetron andmultiple standard-dose ondansetron in chemotherapy-naive pediatric oncology patients. Cancer Investigation 1999;17 (5):309-313 (Pubitemid 29266702)
15. White L, Daly SA, McKenna CJ, Zhestkova N, Leal C, Breatnach F, et al.A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy. Pediatric Hematology and Oncology 2000;17(6):445-455 (Pubitemid 30672627)
16. Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, et al.Symptoms and suffering at the end of life in children with cancer. New England Journal of Medicine 2000;342(5):326-333 (Pubitemid 30075247)
17. Zeltzer LK, Dolgin MJ, LeBaron S, LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics 1991;88(1):34-42.